Skip to main content

Premier Eye Associates Introduces New Dry Eye Treatment: Lumenis OptiPlus

Collingswood, NJ — Premier Eye Associates, a leader in advanced eye care solutions, is proud to announce a groundbreaking new technology in the fight against dry eye disease, the Lumenis OptiPlus. Dry eye disease affects over 20 million people in the United States, a number that is consistently increasing. The complexity of the disease and its root causes demands unique, customized solutions. This newly adopted technology enhances Premier Eye Associates' capability to offer effective dry eye treatment.

"We’ve always been at the forefront of using cutting-edge tech to enhance patient care,” said Dr. Tyler Mills, co-founder of Premier Eye Associates. “What sets the Lumenis OptiPlus apart from our other equipment is how targeted and effective it is for the vast majority of people suffering from chronic dry eye. Dry eye is a disease, not a symptom, so it’s important to make choices that tackle the problem at its root cause.”

According to the National Institutes of Health, up to 86% of dry eye cases are due to meibomian gland dysfunction, which occurs when the meibomian glands become blocked or experience other abnormalities, which affects the composition of the eyes’ tear film. As a result, tear quality drops and they fail to properly lubricate the eyes. The newly acquired technology helps unclog the meibomian glands, restoring tear function.

“Our practice has always stood out as a leader in dry eye disease treatment,” said Premier Eye Associates’ co-founder, Dr. Brian Samartino, O.D. “We develop treatment plans that not only target the root cause but go the extra mile and consider our patients’ lifestyles, too. What works for an office worker may not work for someone with a career in landscaping or law enforcement. We aim to make our solutions comprehensive and multi-layered, and this technology is another very powerful tool in our toolbox.”

The Lumenis OptiPlus is a unique radiofrequency technology that gently heats the eyelids and unblocks the meibomian glands responsible for producing the crucial oils that form the tear film's upper layer. This gentle heating process facilitates the natural flow of healthier, more balanced oils. As a result, the tear film is restored to its optimal state, ensuring better lubrication, reduced irritation, and improved overall eye health.

The treatment has many benefits: it’s noninvasive, painless, requires no down time, and is suitable for all skin types. This new treatment is also a testament to Premier Eye Associates' commitment to patient satisfaction through customized solutions and cutting-edge technology.

For those who are suffering from dry eye disease and want to experience the benefits of the Lumenis OptiPlus Treatment with Premier Eye Associates, schedule an appointment today. Interested parties can visit Premier Eye at their Collingswood location at 571 Haddon Ave, Collingswood, NJ 08108, or call to schedule an appointment at (856) 858-3937.

About Premier Eye Associates

Founded in 2014, Premier Eye Associates has established itself as a leader in eye care services in South Jersey. They serve patients by mixing old-fashioned, friendly service with state-of-the-art tech, which results in the right solutions delivered in ways that are familiar and build trust in patients. Their treatment plans are wholly customized and offer targeted solutions that meet the needs of each individual. When it comes to optical services, their friendly team of knowledgeable eye care professionals offer an authentic shopping experience, highly precise and data-driven eye exams, and an excellent selection of frames and lenses. To learn more, visit


For more information about Premier Eye Associates - Collingswood, contact the company here:

Premier Eye Associates - Collingswood
Dr. Tyler Mills
571 Haddon Ave
Collingswood, NJ 08108

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.